SCHEMBL110459

SCHEMBL110459

CSCC(N)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4992004 1.00
SCHEMBL110458 1.00
SCHEMBL21489523 0.97 SLC7A5 (0.48)
Hydrochloric Acid SCHEMBL7756974 0.97
Hydrochloric Acid SCHEMBL28195056 0.97
Hydrochloric Acid SCHEMBL202708 0.97
SCHEMBL11582175 0.95 PTGS1 (0.50)
Chloroform SCHEMBL28222011 0.93 SLC7A5 (0.44)
Glycine SCHEMBL28312688 0.91 GLRA1 (0.46)
Cysteine SCHEMBL8936195 0.89 PTGS1 (0.70)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1454 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12584924-B2 Compositions and methods for diagnosing and treating chronic kidney disease SOCIETE DES PRODUITS NESTLE S.A. (CH) 2026-03-24 US claimed
WO-2025132533-A1 COMPOSITION COMPRISING AN ALIPHATIC ACID OR SALT THEREOF, AN ANTIOXIDANT, A SPECIFIC COMPOUND SUCH AS BETAINE AND AT LEAST ONE PYRIDINE DERIVATIVE L'OREAL (FR) 2025-06-26 WO claimed
EP-4561555-A2 PLATINUM COMPLEXES, RELATED COMPOSITIONS, AND USES THEREOF IN CYANIDE COUNTERMEASURES Purdue Research Foundation (US) 2025-06-04 EP claimed
WO-2025047832-A1 SKIN COSMETIC COMPOSITION CONTAINING BOTRYOCOCCENE AS ACTIVE INGREDIENT フィコケミー株式会社 2025-03-06 WO claimed
WO-2025017234-A1 HETEROMETALLIC DIMER CATALYST STABILISED IN A METAL-ORGANIC FRAMEWORK WITH METHYLCYSTEINE AND USE THEREOF IN ACETYLENE SEMI-HYDROGENATION UNIVERSITAT DE VALÈNCIA (ES) 2025-01-23 WO claimed
US-20240293476-A1 Methods and Compositions for Changing Metabolite Levels in a Subject ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2024-09-05 US claimed
EP-4417061-A1 FOOD SUPPLEMENT FOR ANIMALS, PREPARATION METHOD THEREOF AND USE OF SAME Adibio, S.l. (ES) 2024-08-21 EP claimed
US-20240228537-A1 BLOCK COPOLYPEPTIDES AND USE THEREOF NATIONAL CHENG KUNG UNIVERSITY (TW) 2024-07-11 US claimed
US-20240197666-A1 DITERPENOID COMPOUNDS THAT ACT ON PROTEIN KINASE C (PKC) K-GEN THERAPEUTICS, INC. (US) 2024-06-20 US claimed
US-20240050409-A1 Methods and Compositions for Treating Psychotic Disorders SOUND PHARMACEUTICALS INCORPORATED 2024-02-15 US claimed
US-4931471-A Amides of paramethoxycinnamic and utilization thereof as solar filters UNIVERSITE LOUIS PASTEUR (FR) 1990-06-05 US claimed
EP-0368284-A2 Process for producing L-threonine KYOWA HAKKO KOGYO CO., LTD. (JP) 1990-05-16 EP claimed
EP-0336387-A2 Process for producing L-arginine KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JP) 1989-10-11 EP claimed
US-4855286-A HYPOTENSIVE AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 1989-08-08 US claimed
US-4772591-A ASCORBIC ACID, CALCIUM SOURCE, ANTIINFLAMMATORY AGENT PERITAIN, LTD. (US) 1988-09-20 US claimed
WO-1987004923-A2 AROMATIC AMIDES ABSORBING THE U.V. ROBERT DOMINIQUE 1987-08-27 WO claimed
US-4647453-A Treatment for tissue degenerative inflammatory disease PERITAIN, LTD. (US) 1987-03-03 US claimed
EP-0178602-A2 Treatment for tissue degenerative inflammatory disease Peritain, Ltd. (US) 1986-04-23 EP claimed
EP-0175180-A1 Histargin-related compounds, a process for their preparation and their use as medicaments MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) 1986-03-26 EP claimed
EP-0105193-A2 Spergualin-related compounds, processes for the preparation thereof and their use as medicaments MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) 1984-04-11 EP claimed